Logo image of SPA.CA

SPANISH MOUNTAIN GOLD LTD (SPA.CA) Stock Fundamental Analysis

TSX-V:SPA - TSX Venture Exchange - CA8464811097 - Common Stock - Currency: CAD

0.16  0 (0%)

Fundamental Rating

2

Taking everything into account, SPA scores 2 out of 10 in our fundamental rating. SPA was compared to 806 industry peers in the Metals & Mining industry. While SPA seems to be doing ok healthwise, there are quite some concerns on its profitability. SPA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SPA had negative earnings in the past year.
SPA had a negative operating cash flow in the past year.
In the past 5 years SPA always reported negative net income.
SPA had a negative operating cash flow in each of the past 5 years.
SPA.CA Yearly Net Income VS EBIT VS OCF VS FCFSPA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

SPA has a better Return On Assets (-2.08%) than 78.91% of its industry peers.
SPA has a Return On Equity of -2.12%. This is amongst the best in the industry. SPA outperforms 80.65% of its industry peers.
Industry RankSector Rank
ROA -2.08%
ROE -2.12%
ROIC N/A
ROA(3y)-1.81%
ROA(5y)-1.45%
ROE(3y)-1.84%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
SPA.CA Yearly ROA, ROE, ROICSPA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 -2

1.3 Margins

SPA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPA.CA Yearly Profit, Operating, Gross MarginsSPA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for SPA has been increased compared to 1 year ago.
Compared to 5 years ago, SPA has more shares outstanding
SPA has a better debt/assets ratio than last year.
SPA.CA Yearly Shares OutstandingSPA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SPA.CA Yearly Total Debt VS Total AssetsSPA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

SPA has an Altman-Z score of 18.16. This indicates that SPA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SPA (18.16) is better than 78.41% of its industry peers.
SPA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
SPA has a Debt to Equity ratio (0.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.16
ROIC/WACCN/A
WACCN/A
SPA.CA Yearly LT Debt VS Equity VS FCFSPA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 2.64 indicates that SPA has no problem at all paying its short term obligations.
SPA has a Current ratio of 2.64. This is in the better half of the industry: SPA outperforms 60.79% of its industry peers.
SPA has a Quick Ratio of 2.64. This indicates that SPA is financially healthy and has no problem in meeting its short term obligations.
SPA has a better Quick ratio (2.64) than 62.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
SPA.CA Yearly Current Assets VS Current LiabilitesSPA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.84% over the past year.
EPS 1Y (TTM)9.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SPA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPA.CA Price Earnings VS Forward Price EarningsSPA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPA.CA Per share dataSPA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SPA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPANISH MOUNTAIN GOLD LTD

TSX-V:SPA (7/31/2025, 7:00:00 PM)

0.16

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)10-27 2025-10-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.7%
Ins Owner ChangeN/A
Market Cap71.16M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.08%
ROE -2.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.81%
ROA(5y)-1.45%
ROE(3y)-1.84%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9347.53%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z 18.16
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)6075.52%
Cap/Depr(5y)6005.21%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.75%
OCF growth 3YN/A
OCF growth 5YN/A